About
Myc Inhibitors
Areas of Focus
Categories
Australia
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
6
As Collaborator
2
Total Enrollment
1,838
By Phase
PHASE4: 2PHASE3: 1PHASE1: 3PHASE2: 2
By Status
COMPLETED: 5RECRUITING: 3
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT07084402Collaborator
Short-term Bactericidal Effect of Contezolid in MAC-PD
PHASE4Recruiting
188 participants
Started: Jul 24, 2025 · Completed: Dec 31, 2027
NCT07213765Collaborator
Short-term Antibiotic Therapy in Mycobacterium Avium Complex Pulmonary Disease
PHASE4Recruiting
188 participants
Started: Jul 24, 2025 · Completed: Dec 31, 2028
NCT05369052Lead Sponsor
Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI)
PHASE3Recruiting
865 participants
Started: May 3, 2022 · Completed: Jun 30, 2026
NCT04649541Lead Sponsor
Study of the Safety, Tolerability, and PK of MRX-8 Administered Intravenously to HVs in SAD and MAD Cohorts
PHASE1Completed
69 participants
Started: Nov 29, 2020 · Completed: Dec 1, 2021
NCT03747497Lead Sponsor
Contezolid Acefosamil Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection
PHASE2Completed
196 participants
Started: Nov 15, 2018 · Completed: Mar 26, 2019
Locations (1)
Headquarters
Melbourne, Australia
Map
Loading map...